Zobrazeno 1 - 10
of 18
pro vyhledávání: '"J. P. Rake"'
Autor:
Elizabeth J. Cathcart-Rake, MD, Amye Tevaarwerk, MD, Aminah Jatoi, MD, Evelyn F. Carroll, MD, NFN Scout, MA, PhD, Victor G. Chedid, MD, MS, Cesar A. Gonzalez, PhD, Kelli Fee-Schroeder, DNP, RN, OCN, Jewel M. Kling, MD, MPH, Chrisandra L. Shufelt, MD, MS, Jennifer L. Ridgeway, PhD, Caroline Davidge-Pitts, MBBCh
Publikováno v:
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 8, Iss 5, Pp 443-450 (2024)
Transgender and gender diverse (TGD) people experience disparities in cancer care, including more late-stage diagnoses, worse cancer-related outcomes, and an increased number of unaddressed and more severe symptoms related to cancer and cancer-direct
Externí odkaz:
https://doaj.org/article/88513ca65db34a9e8cae43fb058ee495
Autor:
Elizabeth J. Cathcart‐Rake, David Zahrieh, Deanne Smith, Susan Young, Shaylene McCue, Amanda O'Connor, Stephan Thomé, Mario Lacouture, Terra Register, Jill Piens, Bret B. Friday, Charles L. Loprinzi
Publikováno v:
Cancer Medicine, Vol 12, Iss 8, Pp 9650-9654 (2023)
Abstract Introduction Nasal symptoms are frequently reported by patients undergoing chemotherapy. Methods Eligible patients planning to receive paclitaxel, docetaxel, nab‐paclitaxel, bevacizumab without a concomitant taxane, or “other” (non‐t
Externí odkaz:
https://doaj.org/article/eef6427d42514b0c9fd6e63b398eebf1
Autor:
Kelly C. Gast, Elizabeth J. Cathcart-Rake, Aaron Norman, Leah Eshraghi, Nwamaka Obidegwu, Fergus Couch, Celine Vachon, Kathryn J. Ruddy
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 3, Iss 1, Pp 1-6 (2019)
Abstract Background Patient-reports of cancer treatments are sometimes used in oncology research and clinically when medical records are unavailable. We aimed to evaluate the accuracy of patient recall in this setting. Materials and methods Participa
Externí odkaz:
https://doaj.org/article/543cf25cb0144c949efee59a7505f24d
Autor:
Shruti R Patel MD, Jacqueline Zayas PhD, Jose R Medina-Inojosa MD, MSc, Charles Loprinzi MD, Elizabeth J Cathcart-Rake, Anjali Bhagra MD, Janet E Olson PhD, Fergus J Couch PhD, Kathryn J Ruddy MD, MPH
Publikováno v:
Global Advances in Health and Medicine, Vol 10 (2021)
Purpose Integrative therapies such as yoga are potential treatments for many psychological and physical symptoms that occur during and/or after treatment for cancer. The purpose of the current study was to evaluate the patient-perceived benefit of yo
Externí odkaz:
https://doaj.org/article/67653ebe7d094fc2b6f3b8d7702303a4
Publikováno v:
Journal of Inherited Metabolic Disease. 21:227-231
storage disease type 1 (GSD-1) is caused by insufficient function of Glycogen glucose-6-phosphatase (G6Pase). This enzyme complex plays a central role in both glycogenolysis and gluconeogenesis, by converting glucose 6-phosphate (G6P) to glucose. De
Autor:
Robert H. J. Bandsma, G. Peter A. Smit, Berthil H.C.M.T. Prinsen, Folkert Kuipers, J. P. Rake, Dirk-Jan Reijngoud, Theo Boer, Monique G. de Sain–Van der Velden
Publikováno v:
Pediatric Research, 63(6), 702-707. Nature Publishing Group
University of Groningen
University of Groningen
Glycogen storage disease type 1a (GSD-1a) is a metabolic disorder characterized by fasting-induced hypoglycemia, hepatic steatosis, and hyperlipidemia. The mechanisms underlying the lipid abnormalities are largely unknown. To investigate these mechan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0592c623e70f54c0a86424284bce8b41
https://research.rug.nl/en/publications/d293e561-1003-41b9-896b-bd43afba49cb
https://research.rug.nl/en/publications/d293e561-1003-41b9-896b-bd43afba49cb
Publikováno v:
Journal of Inherited Metabolic Disease, 26(1), 43-47. SPRINGER
Growth retardation is one of the clinical characteristics of glycogen storage disease (GSD) type IX. Initial growth retardation has been described in a few case reports, followed by a complete catch-up in growth. This study aimed to determine the gro
Autor:
G. Peter A. Smit, Robert H. J. Bandsma, Marc K. Hellerstein, Gepke Visser, Wim van Duyvenvoorde, Hans M.G. Princen, J. P. Rake, Richard A. Neese, Folkert Kuipers, Frans Stellaard
Publikováno v:
Journal of Pediatrics, 140(2), 256-260. MOSBY-ELSEVIER
We describe 2 patients with glycogen storage disease type 1a and severe hyperlipidemia without premature atherosclerosis. Susceptibility of low-density lipoproteins to oxidation was decreased, possibly related to the ~40-fold increase in palmitate sy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02df7cc7e3ba458c43e116e4b4c87299
https://research.rug.nl/en/publications/e3deea10-e141-4bd6-8c91-769bcc659723
https://research.rug.nl/en/publications/e3deea10-e141-4bd6-8c91-769bcc659723
Autor:
Gepke Visser, S. W. Moses, Philippe Labrune, Gerrit Smit, J. P. Rake, J Fernandes, J. V. Leonard, Kurt Ullrich
Publikováno v:
Journal of Pediatrics, 137(2), 187-191. MOSBY-ELSEVIER
Objective: To investigate the incidence, the severity, and the course of neutropenia, neutrophil dysfunction, and inflammatory bowel disease (IBD) in glycogen storage disease (GSD) type Ib. Method: As part of a collaborative European Study on GSD typ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c21519d6ead6d37650dffc3595798aef
https://research.rug.nl/en/publications/771cbfb4-3549-41ac-8aa7-1df7d2cf93c1
https://research.rug.nl/en/publications/771cbfb4-3549-41ac-8aa7-1df7d2cf93c1
Autor:
J P, Rake, A M, ten Berge, G, Visser, E, Verlind, K E, Niezen-Koning, C H, Buys, G P, Smit, H, Scheffer
Publikováno v:
Human mutation. 15(4)
We identified a novel mutation (867delA) in the glucose-6-phosphatase gene of two siblings with glycogen storage disease type Ia. Although both siblings share the same mutations, their phenotype regarding adult height and hepatomegaly differs. In gly